Diversity of structure and function of alpha1alpha6beta3delta GABAA receptors: comparison with alpha1beta3delta and alpha6beta3delta receptors.
delta subunit-containing gamma-aminobutyric acid, type A (GABA(A))receptors are expressed extrasynaptically and mediate tonic inhibition. In cerebellar granule cells, they often form receptors together with alpha(1) and/or alpha(6) subunits. We were interested in determining the architecture of receptors containing both subunits. We predefined the subunit arrangement of several different GABA(A) receptor pentamers by concatenation. These receptors composed of alpha(1), alpha(6), beta(3), and delta subunits were expressed in Xenopus oocytes. Currents elicited in response to GABA were determined in the presence and absence of 3alpha,21-dihydroxy-5alpha-pregnan-20-one (THDOC) or ethanol, or currents were elicited by 4,5,6,7-tetrahydroisoxazolo[5,4-c]-pyridin-3-ol (THIP). Several subunit configurations formed active channels. We therefore conclude that delta can assume multiple positions in a receptor pentamer made up of alpha(1), alpha(6), beta(3), and delta subunits. The different receptors differ in their functional properties. Functional expression of one receptor type was only evident in the combined presence of the neurosteroid THDOC with the channel agonist GABA. Most, but not all, receptors active with GABA/THDOC responded to THIP. None of the receptors was modulated by ethanol concentrations up to 30 mm. Several observations point to a preferred position of delta subunits between two alpha subunits in alpha(1)alpha(6)beta(3)delta receptors. This property is shared by alpha(1)beta(3)delta and alpha(6)beta(3)delta receptors, but there are differences in the additionally expressed isoforms.
Baur
Roland
R
Institute of Biochemistry and Molecular Medicine, University of Bern, CH-3012 Bern, Switzerland.
Kaur
Kuldeep H
KH
Sigel
Erwin
E
D000818:Animals; D001665:Binding Sites; D004305:Dose-Response Relationship, Drug; D009474:Neurons / Q000378:metabolism; D018377:Neurotransmitter Agents / Q000378:metabolism; D009865:Oocytes / Q000378:metabolism; D018408:Patch-Clamp Techniques; D020033:Protein Isoforms; D011963:Receptors, GABA-A / Q000737:chemistry*; D014981:Xenopus / Q000378:metabolism; D005680:gamma-Aminobutyric Acid / Q000494:pharmacology
D018377:Neurotransmitter Agents; D020033:Protein Isoforms; D011963:Receptors, GABA-A; D005680:gamma-Aminobutyric Acid
Eur J Pharmacol. 1995 Aug 15;290(3):175-81
7589211
J Biol Chem. 2002 Nov 29;277(48):46020-5
12324466
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15218-23
14625373
Trends Pharmacol Sci. 2004 Sep;25(9):499-503
15559253
J Neurosci. 2002 May 15;22(10):RC223
12006605
Mol Pharmacol. 1996 Mar;49(3):567-79
8643098
Br J Pharmacol. 2008 Mar;153(5):1062-71
18204487
J Pharmacol Exp Ther. 2006 Mar;316(3):1360-8
16272217
Ann N Y Acad Sci. 1999 Apr 30;868:645-53
10414349
J Neurosci. 1994 Nov;14(11 Pt 2):7077-86
7525894
J Biol Chem. 2009 Mar 20;284(12):7889-96
19141615
Pharmacol Rev. 1998 Jun;50(2):291-313
9647870
Mol Cell Neurosci. 2008 Mar;37(3):610-21
18206389
Synapse. 1995 Nov;21(3):189-274
8578436
J Neurochem. 2003 Dec;87(6):1444-55
14713300
Biochem Soc Trans. 2009 Dec;37(Pt 6):1338-42
19909272
J Neurosci. 1998 Mar 1;18(5):1693-703
9464994
J Neurochem. 2009 Dec;111(5):1172-81
19765192
J Neurosci. 1996 Jan;16(1):103-14
8613776
Eur J Pharmacol. 1998 Apr 24;347(2-3):347-53
9653902
J Neurochem. 2000 Jun;74(6):2590-6
10820222
J Neurosci. 1997 Feb 15;17(4):1350-62
9006978
Curr Top Med Chem. 2002 Aug;2(8):795-816
12171572
Proc Natl Acad Sci U S A. 2004 May 18;101(20):7769-74
15136735
Annu Rev Neurosci. 1994;17:569-602
7516126
J Neurochem. 1996 Feb;66(2):685-91
8592140
J Biol Chem. 2001 Sep 28;276(39):36275-80
11466317
Trends Neurosci. 2004 Sep;27(9):569-75
15331240
FEBS Lett. 2006 Mar 6;580(6):1616-20
16494876
Neuron. 2008 Jul 31;59(2):207-13
18667149
J Pharmacol Exp Ther. 2006 Mar;316(3):1351-9
16272218
Neuron. 1990 Nov;5(5):703-11
1699569
J Neurosci. 2003 Dec 3;23(35):11158-66
14657175
Nat Neurosci. 2007 Jan;10(1):40-8
17159992
Nat Neurosci. 2005 Jun;8(6):797-804
15895085
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14439-44
14623958
J Neurosci. 1998 Apr 1;18(7):2449-57
9502805
Nat Rev Neurosci. 2005 Mar;6(3):215-29
15738957
Mol Pharmacol. 1999 Jul;56(1):110-5
10385690
J Physiol. 1987 May;386:73-90
2445971